Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 | P07550 | 2/20 | 0.39 |
| ▸ | ADRB1 | P08588 | 2/20 | 0.39 |
| ▸ | ADRB3 | P13945 | 2/20 | 0.39 |
| ▸ | AR | P10275 | 1/20 | 0.38 |
| ▸ | ADRA2A | P08913 | 3/20 | 0.38 |
| ▸ | ADRA2B | P18089 | 3/20 | 0.38 |
| ▸ | ADRA2C | P18825 | 3/20 | 0.38 |
| ▸ | ADRA1A | P35348 | 3/20 | 0.38 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.38 |
| ▸ | ESR1 | P03372 | 1/20 | 0.35 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.35 |
| ▸ | HTR2B | P41595 | 2/20 | 0.33 |
| ▸ | HTR2A | P28223 | 1/20 | 0.33 |
| ▸ | HTR2C | P28335 | 1/20 | 0.33 |
| ▸ | PDE2A | O00408 | 1/20 | 0.33 |
| ▸ | GCGR | P47871 | 2/20 | 0.32 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.31 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10302847 | 0.92 | ADRB2 (0.43) | ADRB2ADRB1ADRB3ARADRA2A | |
| SCHEMBL4451075 | 0.78 | AR (0.46) | ADRB2ARADRA2AADRA2BADRA2C | |
| SCHEMBL11965809 | 0.78 | CES2 (0.37) | PDE2A | |
| SCHEMBL20443883 | 0.77 | ADRA1A (0.45) | ADRB2ADRB1ADRB3ADRA2AADRA2B | |
| SCHEMBL10302859 | 0.73 | MMP1 (0.33) | PDE2ALMNA | |
| SCHEMBL10302852 | 0.73 | AKR1C3 (0.42) | ESR1ESR2HTR2AHTR2C | |
| SCHEMBL1998634 | 0.73 | CES2 (0.50) | ADRB2ADRB1ADRB3ADRA2AADRA2B | |
| SCHEMBL12196477 | 0.71 | AR (0.42) | ARESR1ESR2 | |
| SCHEMBL11965807 | 0.71 | ESR2 (0.33) | ESR2PDE2A | |
| SCHEMBL17429416 | 0.71 | TSHR (0.53) | ADRB2ADRB1ADRB3ADRA2AADRA2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110097519-A1 | Liquid Crystal Composition and Liquid Crystal Display Device | CHISSO CORPORATION (JP) | 2011-04-28 | — | — | US | disclosed |
| US-7851032-B2 | Liquid crystal composition and liquid crystal display device | CHISSO CORPORATION (JP) | 2010-12-14 | — | — | US | disclosed |
| US-20090278089-A1 | LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | CHISSO CORPORATION (JP) | 2009-11-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090278089-A1 | LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | VCL, NLK, LASP1 | ADRB2 1600/4885ADRB1 2622/4885ADRB3 3150/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.